Research
Hormonal
Hypothalamic integration of nutritional information via neuropeptides (NPY/AgRP and POMC/CART) and molecular sensors (AMPK, mTOR) is a critical hub for regulating energy balance, with genetic defects in these pathways causing severe obesity.
Genetic factors play a significant role in how the brain regulates hunger and satiety. For some, this regulation is impaired due to genetic defects (e.g., MC4R deficiency). This highlights that obesity is not always a simple lifestyle choice but can have strong biological underpinnings.
StrongSupportsVERY_HIGH confidence
Two populations of neurons, one expressing the powerfully orexigenic peptides NPY and AGRP and the other expressing the anorexigenic peptides proopiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART), located in the ARC of the hypothalamus are the primary integrators of various nutritional information.
Why this rating
Strong evidence from genetic models (monogenic obesity) and molecular studies.
Source
Central and Peripheral Regulation of Food Intake and Physical Activity: Pathways and Genes
Natalie R. Lenard et al. · Obesity · 2008
DOI 10.1038/oby.2008.511
narrative_reviewCited 333×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Peripheral nutrient sensing mechanisms (taste, gut hormones like GLP-1, PYY, CCK, and signals from adipose tissue like leptin) provide critical feedback to the brain to regulate food intake and energy expenditure.Strong
- Modern obesogenic environments override physiological homeostatic controls by overwhelming evolutionarily conserved cognitive, reward, and emotional neural systems that evolved to secure food in sparse conditions.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →